FDA Panel Votes In Favor of Replimune’s Melanoma Treatment
5 news sources are covering this Business story right now — Newsylist is tracking how fast it spreads.
Who reported it (5)
- FDA expert committee votes in favor of Replimune’s melanoma treatment STAT · 12h ago
- Replimune’s twice-rejected melanoma drug prevails in FDA adcomm Fierce Biotech · 12h ago
- Why Is REPL Stock Soaring 127% After Hours Today? Yahoo Finance · 12h ago
- US FDA advisers back Replimune skin cancer drug trial data Reuters · 12h ago
- FDA Panel Votes In Favor of Replimune’s Melanoma Treatment wsj.com · 12h ago broke it first
The story so far
"FDA Panel Votes In Favor of Replimune’s Melanoma Treatment" is generating significant coverage in the Business category, with 5 articles from 5 distinct sources tracked by Newsylist so far.
Outlets currently covering the story include STAT, Fierce Biotech, Yahoo Finance and Reuters. Newsylist measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by Newsylist's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by Newsylist's extractive engine from coverage metadata only — no AI-written claims. Updated 1h ago.
The obvious questions
Why is "FDA Panel Votes In Favor of Replimune’s Melanoma Treatment" trending?
Because 5 independent news sources published 5 articles about it in a short window — a coverage burst Newsylist classifies as a trend.
How does Newsylist measure this trend?
Newsylist scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Momentum
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
People, places & organizations
Topics
Related trends
FDA Announces Recall on Berries Sold in 8 States for Potential E. Coli Contamination
5 news sources are covering this Business story right now — Newsylist is tracking how fast it spreads.
More cases reported in cyclospora outbreak not linked to lettuce: FDA data
5 news sources are covering this Business story right now — Newsylist is tracking how fast it spreads.
Toward a test of medical AI superintelligence
Medical and technology outlets are defining new frameworks to evaluate artificial superintelligence as it approaches clinical trial integration.
Cyclospora and salmonella outbreaks raise concerns about U.S. food safety
7 news sources are covering this Business story right now — Newsylist is tracking how fast it spreads.
Hot Peptide Summer Is Almost Here
5 news sources are covering this Business story right now — Newsylist is tracking how fast it spreads.
Cyclospora outbreak may involve more than lettuce, former CDC lead says
18 news sources are covering this Business story right now — Newsylist is tracking how fast it spreads.